New CVS and Express Scripts Value Based Plans for Oncology

CVS and Express Scripts recently announced new plans to determine price and access to cancer drugs based on value. Learn more about these plans and others, such as Memorial Sloan Kettering’s Drug Abacus here. (Source: Tracey Walker, 4/3/16)

You might also be interested in:

EQRx Scales Disruptive Model of Important New Medicines 01/11/2021
What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
Using AI, NLP and Data Visualization with RWE to Generate… 06/10/2020
AHRQ’s Registries User Guide Gets A New Edition 09/24/2020
HealthEconomics.Com, Scientist.Com Announce HEOR, RWE Partnership 04/10/2020